Santa Barbara, CANCT07516132Now EnrollingIRB Ready

Neovascular Age-Related Macular Degeneration (nAMD) Clinical Trial in Santa Barbara, CA

Access cutting-edge neovascular age-related macular degeneration (namd) treatment through this clinical trial at a research site in Santa Barbara. Study-provided care at no cost to qualified participants.

Sponsored by Ocular Therapeutix, Inc.

Quick Self-Assessment

See if you qualify for this Santa Barbara location

Preparing your pre-screening questions…

Expert Care in Santa Barbara

Access neovascular age-related macular degeneration (namd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neovascular age-related macular degeneration (namd) treatment provided free

Apply for This Santa Barbara Location

Check if you qualify for this neovascular age-related macular degeneration (namd) clinical trial in Santa Barbara, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Santa Barbara

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Santa Barbara site if eligible
  4. 4Begin participation

About This Neovascular Age-Related Macular Degeneration (nAMD) Study in Santa Barbara

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Sponsor: Ocular Therapeutix, Inc.

Who Can Participate

Inclusion Criteria

Participants with a diagnosis of nAMD in the study eye who successfully completed Study OTX-TKI-2023-AMD-301 through Week 104 or Study OTX-TKI-2023-AMD-303 through Week 96
Have adequate ocular media and adequate pupillary dilation in the study eye to permit good quality fundus imaging
Are able and willing to comply with all study requirements and visits
Have provided written informed consent

Exclusion Criteria

Have significant intraocular or periocular infection (bacterial, viral, or fungal) in the study eye within 3 months prior to Day 1
History of intraocular inflammation in the study eye
Have evidence of a rhegmatogenous retinal detachment or visually significant/severe epiretinal membrane, macular hole, tear of the retinal pigment epithelium in the macula, or other macular
Presence of an intercurrent illness or condition that in the opinion of the Investigator, may place the participant at an unacceptable risk, preventing the participant from completing the study or confound the interpretation of study results
Female participants who are pregnant (had a positive urine test at the Baseline visit \[Day 1\]) or breastfeeding or intend to become pregnant during the study, who are unwilling to use 2 forms of highly effective contraception from baseline until they exit the study or at least 3 months after the last study treatment, whichever is later.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Santa Barbara?

Yes, this clinical trial (NCT07516132) has an active research site in Santa Barbara, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neovascular Age-Related Macular Degeneration (nAMD) Treatment Options in Santa Barbara, CA

If you're searching for neovascular age-related macular degeneration (namd) treatment options in Santa Barbara, CA, this clinical trial (NCT07516132) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Santa Barbara research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neovascular age-related macular degeneration (namd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neovascular age-related macular degeneration (namd) clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Santa Barbara, CA

See all rheumatoid arthritis clinical trials recruiting in Santa Barbara — not just this study.

Browse Rheumatoid Arthritis Trials in Santa Barbara →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsErectile Dysfunction TrialsMacular Degeneration TrialsAll Conditions →

Ready to Join in Santa Barbara?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Santa Barbara, CA